Objective. Our objective was to compare the accuracy of preoperative positron emission tomography (PET)/computed tomography (CT) and contrast-enhanced CT (CECT) in detecting cervical nodal metastases in patients treated with neck dissection and to scrutinize the ability of each modality to determine nodal stage.
important prognosticators. The presence of cervical lymph node metastases is associated with a decrease in long-term survival and warrants escalated treatment plans. 2, 3 To stage and treat patients appropriately, prompt, accurate tumor evaluation and localization are required. 4 Imaging is invaluable in the detection of metastases to the cervical lymph nodes. 5 In patients with clinically negative neck examinations, elective neck therapy is advised if risk of occult metastasis exceeds 15% to 20%. 6, 7 Unfortunately, the rate of undetected metastatic disease with conventional imaging modalities is estimated to be .30%. 7, 8 To reduce the number of unnecessary neck dissections yet appropriately employ these treatments when warranted, radiological advances seek to improve upon the ability to accurately rule in or rule out cervical metastatic disease.
Contrast-enhanced computed tomography (CECT) and magnetic resonance imaging (MRI) are established modalities in the pretherapeutic staging of HNSCC, characterizing tumor size, vessel infiltration, and cervical lymph node metastases. 2, 9 Some propose CECT as first-line, owing to its high reliability and accessibility to assess the upper aerodigestive anatomy and cervical nodal basins simultaneously. 10 Others propose the newer fluorodeoxyglucose (FDG) positron emission tomography (PET) combined with low-dose noncontrast computed tomography (PET/CT) as the more accurate modality. 5, [11] [12] [13] [14] [15] [16] [17] [18] [19] However, using PET/CT alone for preoperative planning can be problematic due to limited resolution and high false-positive rates. 20 Thus, our objectives were (1) to assess and compare the accuracy of PET/CT and CECT in detecting cervical nodal metastases and (2) to scrutinize the ability of each modality and the combination of these modalities to accurately determine nodal stage.
Materials and Methods

Study Patients
A retrospective chart review of all adult patients with HNSCC who underwent neck dissection for initial treatment between 2006 and 2014, as well as received both PET/CT and CECT preoperatively, was approved by the Montefiore Medical Center institutional review board. In total, 214 patients received neck dissection as initial treatment, and 86 were evaluated preoperatively with both imaging modalities within 6 months of surgery. Other exclusion criteria included partial treatment prior to imaging (n = 2), incomplete pathology report (n = 1), presence of human immunodeficiency virus (HIV) infection (n = 1), incomplete study (base of skull to lower mandible, n = 1), or irretrievable studies (Picture Archiving and Communications System [PACS] error, n = 8). In total, the study cohort comprised 73 patients.
Imaging
For 18 F-FDG-PET imaging, all patients were asked to fast for 41 hours prior to intravenous administration of a weight-adjusted dose of 5.18 MBq/kg (0.14 mCi/kg) 18 F-FDG. Images from the base of skull to mid-thighs were acquired on a Philips Gemini TF TOF PET/CT scanner (Philips Medical Systems, Cleveland, Ohio) with a spatial resolution of 5 mm in the center of the field of view, with emission scan acquired at 100 seconds per frame in 3dimensional acquisition mode. CT scanning was performed in spiral mode from mid-thighs to the base of skull at 100 mAs and 120 keV. No contrast medium was used during the CT scan. Proprietary vendor-provided software was used for image reconstruction with the LISTMODE ordered subset/ expectation maximization reconstruction algorithm (3 iterations, 33 subsets). Low-dose CT scan was used for nonuniform attenuation correction. Scatter and random coincidence corrections were performed by vendor-provided programming.
The patients underwent CECT with various systems over an 8-year period. The units included a 64 multidetector CT scanner (LightSpeed Advantage; GE Healthcare, Chicago, Illinois) and a 16/64 multidetector scanner (Philips Brilliance, Andover, Massachusetts). The region of interest extended from the base of skull to the upper mediastinum. Scanning parameters were as follows: section thickness, 0.0625 mm; standard field of view by patient dimensions; voltage, 120 kV; weight-based tube current; and matrix 512 3 512. Images were reconstructed with a slice thickness of 3 mm in soft tissue and bone windows (per department protocols 
Surgery and Histopathology
All patients underwent primary tumor resection and neck dissection. A selective neck dissection-involving I/II/III, II/III, II/III/IV, II/III/IV/VI, or other combination-or radical neck dissection was planned after review of the primary tumor site, pathology, imaging data, clinical exam, and stage at the HNSCC multidisciplinary tumor board, according to the American Joint Committee on Cancer (AJCC) guidelines. 21 As per operative reports, cervical lymph nodes were resected en bloc with intraoperative labeling of the appropriate cervical level. 22 Lymph nodes were dissected from specimens and stained with hematoxylin and eosin for histologic examination. Per institutional standard of care, 1 slide was made for each lymph node. Subsequently, the size, location, and number of metastatic nodes were documented in pathology reports.
Image Interpretation
PET/CT images were interpreted by 3 board-certified nuclear medicine physicians (R.M.M., A.V., and T.A.). All cervical lymph nodes with increased focal tracer uptake, compared with background and blood pool activity with asymmetric distribution, were considered suspicious for metastatic involvement. Standardized uptake value-based criteria were not instituted.
CECT images were interpreted by 3 CAQ-certified (certificates of added qualifications) neuroradiologists (K.S., E.G., and M.N.). Any cervical lymph node satisfying at least 1 of the following criteria was considered suspicious for metastatic involvement: necrosis; extranodal extension; round or irregular shape with enhancement, size .0.5 cm (shortest axial diameter); round or irregular shape without enhancement, size .1.0 cm; oval shape with enhancement, size .1.0 cm; oval shape without enhancement, size .1.5 cm; or grouping of 2 or more lymph nodes. 23, 24 Cervical regions were divided into 8 levels on each side (IA, IB, IIA, IIB, III, IV, VA, VB) according to consensus definitions set forth by the American Head and Neck Society 22 and by Som et al. 25 When lymph nodes were determined positive for metastasis by imaging criteria, both corresponding neck level and side were marked positive for statistical analysis. PET/CT and CECT imaging results were independently compared with histopathology results.
Staging
Using morphological data from PET/CT or CECT studies, a preoperative imaging-based nodal stage (iN) was assigned to each patient according to AJCC criteria. 26 For each modality, the consensus iN stage for a given patient was the iN stage designated by 2 or more readers. The gold standard for comparison was the final nodal stage (N) as determined by histopathology. Agreement between iN and N stages was assessed using Cohen's k coefficient.
Statistical Analysis
Interreader agreement for PET/CT and CECT readers was assessed using Cohen's k coefficient. Independent coefficients were calculated for each possible pair of PET/CT readers and CECT readers, as well as a coefficient describing the collective agreement (among all 3 readers) using a variation of the k coefficient. For each imaging modality, the neck level or neck side was considered positive for statistical analyses if at least 2 of the 3 readers agreed on metastatic involvement.
Concordance between imaging and histopathology was evaluated based on the aforementioned anatomic neck level, independent of side. In addition, an independent analysis evaluated the concordance for neck side alone, better controlling for intraoperative variability. The sensitivity, specificity, overall accuracy, positive predictive value, and negative predictive value in detecting metastatic lymph nodes were calculated for each modality. A 2-sample proportion test was used to compare the corresponding proportions for PET/CT and CECT. A P value of .05 or less was considered statistically significant.
Results
Patients received preoperative PET/CT and CECT a median of 23 (range, 1-104 days) and 31 days (range, 6-191 days) prior to surgery, respectively. The clinicopathologic characteristics of the cohort are presented in Table 1 . In total, 579 neck-level specimens corresponding with 116 neck sides were sent to pathology. Eighty-three of 579 (14%) resected neck levels and 53 of 116 (46%) resected neck sides showed histological evidence of metastatic involvement. The most common primary tumor site was the oral cavity (49%), followed by the oropharynx (21%). By pathology, 27 (37%) patients were staged N0, 9 (12%) were staged N1, 35 (48%) were staged N2, and 2 (3%) were staged N3. Fifty-six (77%) patients had overall stage III or IV disease at the time of treatment. The preoperative iN stage designations assigned by each PET/CT and CECT reader are presented in Table 2 .
Of 73 patients, 44 (60%) underwent bilateral neck dissection, and 29 (40%) underwent unilateral neck dissection. Of 27 N0 patients without evidence of cervical metastasis on pathology, 14 (52%) patients received ipsilateral neck dissection, and 13 (48%) received bilateral neck dissection. Of 58 patients with primary tumor laterality, 33 (57%) had ipsilateral lymph node disease, 6 (10%) had bilateral involvement, 2 (3%) had contralateral nodal metastases without ipsilateral disease, and 17 (29%) had no cervical lymph node involvement.
When assessing concordance between imaging and pathology by neck level, PET/CT was found to correctly identify occult metastases in 57 of 83 (69%) positive neck levels, while CECT was found to identify 44 of 83 (53%) positive neck levels ( Table 3) . Absence of occult metastasis was correctly reported in 424 of 496 (86%) and 450 of 496 (91%) negative neck levels, using PET/CT and CECT, respectively. No significant difference was found between PET/CT and CECT in terms of sensitivity (P = .056). Although CECT was more specific (P = .014), there was no significant difference in overall accuracy (P = .33). In 1 patient with a false-positive PET/CT, the presence of a fatty hilum on CECT accurately ruled out metastatic disease ( Figure 1 ). However, in another patient, fatty hilum incorrectly ruled out a level IB lymph node found to be positive for metastatic disease on both PET/ CT and pathology ( Figure 2) . When an independent analysis was performed evaluating neck laterality rather than nodal station, PET/CT was found to correctly identify the presence of occult metastases in 50 of 53 (94%) positive neck sides, while CECT was found to correctly identify 35 of 53 (66%) positive neck sides ( Table 3) . Absence of cancer involvement was correctly reported in 35 of 63 (56%) and 48 of 63 (76%) negative neck sides, using PET/ CT and CECT, respectively. Of the 38 neck sides determined negative by PET/CT, only 3 were subsequently found to be positive for disease on pathologic evaluation, yielding a falsenegative rate of 8%. PET/CT was found to be more sensitive (P = .001) in this analysis although remained less specific than CECT (P = .024). Overall accuracy between the 2 modalities did not differ significantly (P = .88).
Of the 27 N0 patients who had no evidence of cervical metastasis on pathology, 16 (59%) patients were assigned a preoperative stage of iN1 or higher by PET/CT, whereas 8 (30%) patients were assigned a higher preoperative stage by CECT. The nodal staging assignments yielded by PET/CT and CECT for each pathology stage are further described in Table 4 . The overall agreement percentages between iN stage called by imaging modality compared with pathology N stage were 52% and 55% for PET/CT and CECT, respectively ( Table 5 ). When preoperative iN and pathology N stage assignments were discordant, 37% of patients were overstaged by PET/CT data, whereas 19% of patients were overstaged by CECT. Twenty-six percent of patients were understaged by CECT compared with 11% by PET/CT.
The k coefficient values demonstrated moderate agreement (k = 0.53-0.68) for PET/CT and almost perfect agreement (k = 0.88-1.00) for CECT, assessing interreader agreement for positive determinations of cervical lymph node metastases by neck level and by neck side. Assessing interreader agreement for preoperative iN stage assignments demonstrated moderate agreement (k = 0.46-0.71) for PET/ CT and almost perfect agreement (k = 0.85-0.94) for CECT. Abbreviations: CECT, contrast-enhanced computed tomography; CI, 95% confidence interval; CT, computed tomography; 18 F-FDG, 18 
Discussion
In the present study, we compared the accuracy of PET/CT and CECT in detecting occult metastases to cervical lymph nodes in previously untreated patients with HNSCC. We assessed the clinical usefulness of the 2 modalities for nodal staging by comparing preoperative iN stage assignments to pathology N stage assignments as the gold standard. Our results add to the limited literature on the efficacy of PET/ CT in preoperative nodal staging: PET/CT stages nodal involvement more accurately than conventional imaging, 13 PET/CT may be more useful than CECT for nodal staging, 27 and PET/CT leads to upstaging and changes in patient management. 28 Our results cannot confirm that PET/ CT overstages cervical lymph node disease. Moreover, the data show that PET/CT offers no overall accuracy advantage over CECT in the preoperative staging of HNSCC. Although concordance between preoperative iN stages and pathology N stages was~50% for both PET/CT and CECT, 37% of calls were overstaged by PET/CT while 19% were overstaged by CECT. Neither modality should be used in isolation to preoperatively stage cervical lymph node involvement. Rather, the development of criteria incorporating information gleaned from both PET/CT and CECT may improve the accuracy of preoperative cervical lymph node assessment.
In our study, all imaging studies were evaluated by 3 independent radiologists to evaluate the accuracy and reproducibility of all PET/CT and CECT results. PET and PET/ CT are known to have excellent interreader agreement for the detection of distant metastasis and for the assessment of response to therapy in patients with HNSCC. 29, 30 However, ours compares the interreader agreement for PET/CT and CECT for the detection and staging of preoperative cervical lymph node metastasis. Our findings suggest that CECT has higher interreader agreement (0.85-1) than PET/ CT (0.46-0.71) for both staging as well as neck-level and neck side evaluation. These data may suggest that heuristics for identifying metastatic lymph nodes for CECT are more standardized, while standards for PET/CT require further development. Several studies propose various standardized uptake value (SUV) cutoffs (2.0-3.5) during PET/ CT evaluations to help prognosticate pretreatment metastatic disease or monitor posttreatment cervical lymph nodes. [31] [32] [33] Others propose a system of graded size-based SUV max cutoffs, 13 but additional interinstitutional investigation will be necessary to confirm universal utility of an SUV cutoff in nodal evaluation.
Our findings suggest that PET/CT is more sensitive than CECT in detecting the presence of cervical lymph node metastases only when ruling out disease to a given neck side, which is in accordance with previous studies. 5, [11] [12] [13] [14] [15] [16] [17] [18] [19] In particular, PET/CT was 28% more sensitive than CECT in detecting neck sides that contained metastatic lymphadenopathy (P = .001). Fifty of 53 (94%) positive neck sides were correctly identified by PET/CT. Of 38 neck sides deemed negative by PET/CT, only 3 were found to have evidence of disease, yielding a false-negative rate of 8%, whereas the false-negative rate for CECT on neck side analysis was 27% (18 of 66). The ability to deem a neck free of disease with high confidence would be clinically relevant, reducing the number of unproductive nodal dissections or radiation therapy. However, no overall difference in sensitivity was found between the 2 modalities, as evidenced by the lack of statistical significance on neck level-based analysis (P = .056). Neither modality was particularly sensitive in detecting neck levels containing metastatic lymphadenopathy (69% for PET/CT and 53% for CECT). PET/CT had a 19% higher NPV than CECT, with pretest prevalence at 46% of dissected neck sides (P = .034). Both morphological and functional imaging modalities are limited in their ability to detect micrometastases in individual lymph nodes at specific neck levels, as shown in previous studies. 17, 34 In their own 70-person cohort and review of prior studies, Nahmias et al 35 reported that PET/CT lacked the sensitivity to clinically help the surgeon due to a high rate of false-negative nodes. Our 0  0  3  0  N2b  4  3  0  12  1  1  0  21  57  N2c  2  1  0  5  3  0  0  11  27  N3  0  0  0  0  0  2  0  2  100  Total  28  13  0  21  8  3  0  73  %C  68  31  0  57  38  67  PA: /CT  6  4  4  23  52  5  3  3  0  CECT  4  3  3  10  55  12  4  7  3  OVERSTAGED  TRUE  UNDERSTAGED  PET/CT  37  52  11  CECT  19  55  26 Abbreviations: CECT, contrast-enhanced computed tomography; CT, computed tomography; PET, positron emission tomography. a Column headers are measurements of the deviation between stage (N0, N1, N2a, N2b, N2c, N3) on imaging vs pathology. All values are presented as percentages.
data largely support these findings, with the exception that PET/CT was effective in ruling out nodal involvement of a neck side. Our findings also suggest that CECT is more specific than PET/CT. Although prior studies have shown that CECT is more specific than PET/CT in the detection of extranodal extension, 36 our study found that CECT was 5% (by neck level) and 20% (by neck side) more specific than PET/CT in the overall identification of metastatic lymph nodes (P = .014, P = .024). On neck side analysis, CECT was found to have a false-positive rate of 30% (15 of 50), compared with 36% (28 of 78) for PET/CT. Nearly 60% of N0 patients would have been overstaged (iN1 or higher) by PET/CT data. As the more conservative modality, CECT is more accurate in confirming the presence of metastasis than PET/CT, contrary to previous studies. 17, 19 Nevertheless, both modalities were found to have high false-positive rates in detecting metastatic disease to a given neck side. The major limitation of PET/CT is well known: inflammatory lymph nodes may have as much tracer uptake as metastatic lymph nodes. 37 Morphological data from CECT studies can supplement the PET/CT evaluation, ultimately helping to delineate metastatic from benign lymph. Recent prospective studies have suggested that PET/CT may have stronger prognostic value than conventional imaging modalities when used to stage patients. 19, 38 This effect was unable to be measured retrospectively but should be further validated.
Our study is limited as a single-institution retrospective study. Due to the retrospective nature, a standardized intraoperative protocol for labeling nodes from cervical levels could not be implemented. Another limitation is that patients with a variety primary tumor sites, with corresponding metastatic potentials, were included. To compare PET/CT and CECT, 98 patients were excluded from the original cohort if only 1 modality was used in the preoperative evaluation, potentially introducing selection bias. Because 10 CECT studies and 4 PET/CT studies were performed over 60 days prior to surgery, median times were calculated so as not to overweight these studies. The complete temporal distribution of imaging studies performed prior to neck dissection can be found in Supplemental Figure S1 (available in the online version of the article). Median time between PET/CT and surgery was 1 week shorter than the median time between CECT and surgery (P = .001). The accuracy of both modalities is likely underestimated and conservative by including studies performed up to 27 weeks prior to surgery. It may be true that the accuracy of these imaging modalities could be improved using a strategy that incorporates pretest probabilities for cervical lymph node metastasis, based on a combination of clinical data (site, stage, clinical exam, etc). Such a study would require a larger cohort and be validated using 1 or several external data sets. Last, the scope of our study was narrow and our analyses did not incorporate routinely used methods of preoperative staging such as clinical stage with physical exam, ultrasound-guided fine-needle aspiration or core needle biopsy, sentinel node biopsy, or focused magnetic resonance imaging. A multicenter prospective design would better lend itself to researching these preoperative options.
Conclusion
In conclusion, PET/CT was more sensitive than CECT in excluding metastatic involvement of a given neck side. However, no difference in overall sensitivity was found between the 2 modalities. CECT was found to have superior specificity compared with PET/CT. Broadly speaking, the information gleaned from PET/CT and CECT for pretreatment evaluation of HNSCC appears to be complementary, suggesting a benefit of using contrast to improve upon the diagnostic yield of PET/CT studies. Continued refinement of the application and reporting for these modalities (eg, greater standardization of the criteria for reporting suspicious cervical lymph nodes on PET/CT) may improve the ability to accurately assess cervical lymph nodes in patients with HNSCC.
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